Evidence map›Paper›PMID 39681620›Full record

ArticleScientific reports2024

Forceps minor control of social behaviour.

Franziska Stoller, Eleanor Hinds, Tudor Ionescu, Elmira Khatamsaz, Hugh M Marston, Bastian Hengerer

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Franziska StollerBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Eleanor HindsBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Tudor IonescuBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Elmira KhatamsazBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Hugh M MarstonBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Bastian HengererBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. bastian.hengerer.ext@boehringer-ingelheim.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The PRISM project, funded by the EU's Innovative Medicines Initiative, has identified a transdiagnostic, pathophysiological relationship between the integrity of the default mode network (DMN) and social dysfunction. To explore the causal link between DMN integrity and social behaviour, we employed a preclinical back-translation approach, using focal demyelination of the forceps minor to disrupt DMN connectivity in mice. By applying advanced techniques such as functional ultrasound imaging and automated analysis of social behaviour, we demonstrated that reduced DMN connectivity leads to impaired social interactions and increased anxiety in mice. Notably, these effects were reversible, indicating that the forceps minor, a critical fibre tract connecting key DMN regions in the prefrontal cortex, plays a crucial role in social function. This study provides direct evidence for a causal relationship between DMN integrity and social dysfunction, with potential implications for developing targeted treatments in precision psychiatry.

Indexed as

Social BehaviorAnimalsAnxietyBehavior, AnimalDefault Mode NetworkMaleMiceMice, Inbred C57BLPrefrontal Cortex

Identifiers

PMID39681620
PMCPMC11649767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.